Organigram Global (OGI) Short Interest Ratio & Short Volume $1.45 -0.01 (-0.68%) Closing price 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.69%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Organigram Global Short Interest DataOrganigram Global (OGI) has a short interest of 5.62 million shares, representing 6.22% of the float (the number of shares available for trading by the public). This marks a -4.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.3, indicating that it would take 10.3 days of the average trading volume of 663,548 shares to cover all short positions.Current Short Interest5,620,000 sharesPrevious Short Interest5,890,000 sharesChange Vs. Previous Month-4.58%Dollar Volume Sold Short$7.59 millionShort Interest Ratio10.3 Days to CoverLast Record DateJune 30, 2025Outstanding Shares133,940,000 sharesFloat Size90,410,000 sharesShort Percent of Float6.22%Today's Trading Volume492,842 sharesAverage Trading Volume663,548 sharesToday's Volume Vs. Average74% Short Selling Organigram Global? Sign up to receive the latest short interest report for Organigram Global and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOGI Short Interest Over TimeOGI Days to Cover Over TimeOGI Percentage of Float Shorted Over Time Organigram Global Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20255,620,000 shares $7.59 million -4.6%6.2%10.3 $1.35 6/15/20255,890,000 shares $8.25 million -3.3%6.5%11.2 $1.40 5/31/20256,090,000 shares $8.05 million -0.8%6.7%11.5 $1.32 5/15/20256,140,000 shares $7.61 million -7.7%6.8%9.9 $1.24 4/30/20256,650,000 shares $7.71 million +21.1%8.0%8.3 $1.16 4/15/20255,490,000 shares $5.71 million -9.7%6.6%6.5 $1.04 3/31/20256,080,000 shares $6.14 million +17.8%7.3%7.1 $1.01 3/15/20255,160,000 shares $5.31 million -4.4%6.2%5.6 $1.03 2/28/20255,400,000 shares $6.21 million +25.6%6.5%5.4 $1.15 2/15/20254,300,000 shares $5.46 million +58.1%4.8%4.7 $1.27 Get the Latest News and Ratings for OGI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organigram Global and its competitors with MarketBeat's FREE daily newsletter. 1/31/20252,720,000 shares $4.08 million +1.1%3.0%3.4 $1.50 1/15/20252,690,000 shares $4.14 million -3.9%3.0%4 $1.54 12/31/20242,800,000 shares $4.51 million +4.1%3.3%4.2 $1.61 12/15/20242,690,000 shares $3.98 million +3.1%3.6%4.3 $1.48 11/30/20242,610,000 shares $3.94 million -5.1%3.4%5.1 $1.51 11/15/20242,750,000 shares $3.96 million +20.1%3.6%5.9 $1.44 10/31/20242,290,000 shares $3.92 million -8.4%3.0%4.3 $1.71 10/15/20242,500,000 shares $4.33 million +1.6%3.3%4.7 $1.73 9/30/20242,460,000 shares $4.45 million -8.9%3.3%4.3 $1.81 9/15/20242,700,000 shares $5.02 million -3.2%3.6%4.5 $1.86 8/31/20242,790,000 shares $5.16 million -19.6%3.8%4.5 $1.85 8/15/20243,470,000 shares $6.91 million -5.7%4.6%5 $1.99 7/31/20243,680,000 shares $6.18 million -5.9%4.9%5.2 $1.68 7/15/20243,910,000 shares $6.69 million +0.8%5.2%4.2 $1.71 6/30/20243,880,000 shares $5.98 million -0.5%5.2%3.7 $1.54 6/15/20243,900,000 shares $5.95 million +2.6%5.2%2.6 $1.53 5/31/20243,800,000 shares $6.50 million -10.0%5.3%2.4 $1.71 5/15/20244,220,000 shares $8.14 million +9.3%5.8%2.7 $1.93 4/30/20243,860,000 shares $8.18 million +7.8%5.9%2.5 $2.12 4/15/20243,580,000 shares $6.73 million +0.3%5.4%2.5 $1.88 3/31/20243,570,000 shares $7.68 million +0.6%5.4%2.5 $2.15 3/15/20243,550,000 shares $7.35 million -0.3%5.4%3.4 $2.07 2/29/20243,560,000 shares $7.37 million -14.6%5.4%3.9 $2.07 2/15/20244,170,000 shares $8.38 million +4.0%6.8%4.8 $2.01 1/31/20244,010,000 shares $6.66 million +1.5%7.6%4.6 $1.66 1/15/20243,950,000 shares $6.68 million +2.1%6.0%2.9 $1.69 12/31/20233,870,000 shares $5.07 million -7.9%5.9%3.2 $1.31 12/15/20234,200,000 shares $5.59 million -1.2%6.4%3.5 $1.33 11/30/20234,250,000 shares $5.44 million +1.2%6.5%3.5 $1.28 11/15/20234,200,000 shares $5.25 million +30.8%6.4%3.4 $1.25A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/31/20233,210,000 shares $3.37 million +6.6%4.9%2.7 $1.05 10/15/20233,010,000 shares $3.46 million +7.1%4.6%6.1 $1.15 9/30/20232,810,000 shares $3.71 million No Change4.3%4.7 $1.32 9/15/20232,810,000 shares $5.11 million +7.7%4.3%4.7 $1.82 8/31/20232,610,000 shares $4.28 million +17.6%4.0%4.9 $1.64 8/15/20232,220,000 shares $2.93 million -11.2%3.4%4.8 $1.32 7/31/20232,500,000 shares $3.80 million +3.7%3.8%5.7 $1.52 7/15/20232,410,000 shares $3.76 million +1.3%3.7%6.4 $1.56 6/30/20232,380,000 shares $3.71 million -73.9%N/A7.8 $1.56 6/15/20239,120,000 shares $3.76 million -14.6%N/A8.9 $0.41 5/31/202310,680,000 shares $3.96 million +22.1%N/A10.4 $0.37 5/15/20238,750,000 shares $4.11 million No ChangeN/A10.3 $0.47 4/30/20238,750,000 shares $4.38 million +26.1%N/A10.6 $0.50 4/15/20236,940,000 shares $3.85 million +7.9%N/A7.8 $0.56 3/31/20236,430,000 shares $4.12 million -0.3%N/A6.1 $0.64 3/15/20236,450,000 shares $4.13 million -3.3%N/A6 $0.64 2/28/20236,670,000 shares $5.26 million +23.8%N/A5.7 $0.79 2/15/20235,390,000 shares $4.54 million -11.8%N/A4.3 $0.84 1/31/20236,110,000 shares $5.55 million -1.0%N/A4.8 $0.91 1/15/20236,170,000 shares $6.11 million -17.0%N/A4.9 $0.99 12/30/20227,430,000 shares $5.94 million -4.6%N/A6.6 $0.80 12/15/20227,790,000 shares $6.93 million -4.0%N/A6.5 $0.89 11/30/20228,110,000 shares $8.35 million -8.2%N/A6.9 $1.03 11/15/20228,830,000 shares $9.01 million +2.7%N/A8.6 $1.02 10/31/20228,600,000 shares $8.77 million -15.6%N/A6.7 $1.02 10/15/202210,190,000 shares $9.21 million +12.2%N/A7.4 $0.90 9/30/20229,080,000 shares $7.91 million +3.2%N/A5.1 $0.87 9/15/20228,800,000 shares $9.06 million +1.6%N/A4.9 $1.03 8/31/20228,660,000 shares $9.27 million -17.0%N/A4.5 $1.07 8/15/202210,430,000 shares $12.93 million +3.6%N/A4.3 $1.24 7/31/202210,070,000 shares $10.77 million +0.4%N/A3.2 $1.07 7/15/202210,030,000 shares $10.13 million -11.2%N/A2.6 $1.01 6/30/202211,290,000 shares $10.35 million -14.5%N/A2.7 $0.92 6/15/202213,210,000 shares $12.90 million -2.2%N/A2.5 $0.98 5/31/202213,500,000 shares $15.53 million -9.8%N/A2.4 $1.15 5/15/202214,960,000 shares $18.40 million +5.4%N/A2.7 $1.23 4/30/202214,200,000 shares $20.02 million -4.8%N/A2.6 $1.41 4/15/202214,910,000 shares $25.94 million +10.8%N/A2.9 $1.74 3/31/202213,460,000 shares $22.34 million -10.8%N/A2.5 $1.66 3/15/202215,090,000 shares $20.67 million +0.7%N/A3.1 $1.37 2/28/202214,990,000 shares $22.34 million -2.2%N/A2.9 $1.49 2/15/202215,320,000 shares $26.20 million -10.8%N/A2.6 $1.71 1/31/202217,170,000 shares $25.58 million +6.5%N/A2.3 $1.49 1/15/202216,130,000 shares $26.45 million +8.9%N/A2.2 $1.64 12/31/202114,810,000 shares $25.92 million +6.2%N/A2 $1.75 12/15/202113,950,000 shares $25.39 million -4.6%N/A1.9 $1.82 11/30/202114,620,000 shares $29.82 million -15.5%N/A2 $2.04 11/15/202117,300,000 shares $41.17 million +28.1%N/A2.5 $2.38 10/29/202113,510,000 shares $29.86 million -7.3%N/A2.4 $2.21 10/15/202114,580,000 shares $32.66 million +2.5%N/A2.7 $2.24Trump’s worst nightmare (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 9/30/202114,220,000 shares $32.71 million -10.9%N/A2.5 $2.30 9/15/202115,950,000 shares $38.60 million -14.4%N/A2.9 $2.42 8/31/202118,630,000 shares $49.74 million +9.0%N/A3.3 $2.67 8/13/202117,100,000 shares $49.59 million -2.7%N/A2.7 $2.90 7/30/202117,580,000 shares $46.06 million +12.8%N/A2.8 $2.62 7/15/202115,580,000 shares $41.60 million +7.5%N/A2.3 $2.67 6/30/202114,490,000 shares $41.44 million +4.9%N/A1.9 $2.86 6/15/202113,820,000 shares $42.57 million +16.2%N/A1.7 $3.08 5/28/202111,890,000 shares $38.17 million -13.6%N/A1 $3.21 5/14/202113,760,000 shares $33.44 million -9.7%5.8%1.1 $2.43 4/30/202115,230,000 shares $41.58 million +10.3%6.4%0.7 $2.73 4/15/202113,810,000 shares $35.91 million +17.9%5.8%0.6 $2.60 3/31/202111,710,000 shares $39.93 million -17.5%6.6%0.5 $3.41 3/15/202114,200,000 shares $63.05 million +26.1%8.2%0.6 $4.44 2/26/202111,260,000 shares $34.68 million -1.5%4.9%0.5 $3.08 2/12/202111,430,000 shares $41.95 million +36.9%5.0%0.5 $3.67 1/29/20218,350,000 shares $15.95 million -8.3%3.6%0.5 $1.91 1/15/20219,110,000 shares $16.40 million -1.5%4.0%0.8 $1.80 12/31/20209,250,000 shares $12.67 million -27.9%4.0%1 $1.37 12/15/202012,820,000 shares $16.54 million -19.4%5.6%1.7 $1.29 11/30/202015,910,000 shares $21.16 million +11.3%6.9%2.3 $1.33 11/15/202014,290,000 shares $16.15 million -2.7%6.2%2.9 $1.13 10/30/202014,690,000 shares $17.92 million +1.2%7.6%3.8 $1.22 10/15/202014,520,000 shares $17.42 million -4.4%7.5%5.3 $1.20 9/30/202015,180,000 shares $15.94 million -4.7%7.9%5.1 $1.05 9/15/202015,930,000 shares $17.12 million +4.3%8.2%5 $1.08 8/31/202015,280,000 shares $19.25 million +1.7%7.9%4 $1.26 8/14/202015,030,000 shares $22.09 million -1.3%7.8%2.9 $1.47 7/31/202015,230,000 shares $18.73 million +9.2%7.9%2.6 $1.23 OGI Short Interest - Frequently Asked Questions What is Organigram Global's current short interest? Short interest is the volume of Organigram Global shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 5,620,000 shares of OGI short. 6.22% of Organigram Global's shares are currently sold short. Learn More on Organigram Global's current short interest. What is a good short interest ratio for Organigram Global? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGI shares currently have a short interest ratio of 10.0. Learn More on Organigram Global's short interest ratio. What is a good short interest percentage for Organigram Global? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.22% of Organigram Global's floating shares are currently sold short. Is Organigram Global's short interest increasing or decreasing? Organigram Global saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 5,620,000 shares, a decrease of 4.6% from the previous total of 5,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organigram Global's float size? Organigram Global currently has issued a total of 133,940,000 shares. Some of Organigram Global's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organigram Global currently has a public float of 90,410,000 shares. How does Organigram Global's short interest compare to its competitors? 6.22% of Organigram Global's shares are currently sold short. Here is how the short interest of companies compare to Organigram Global: Aurora Cannabis Inc. (12.25%), Cronos Group Inc. (1.43%), SNDL Inc. (1.21%), Tilray Brands, Inc. (20.64%), Village Farms International, Inc. (35.94%), Gyre Therapeutics, Inc. (11.07%), Vir Biotechnology, Inc. (6.45%), Ginkgo Bioworks Holdings, Inc. (31.50%), Xeris Biopharma Holdings, Inc. (5.05%), Replimune Group, Inc. (14.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Organigram Global stock? Short selling OGI is an investing strategy that aims to generate trading profit from Organigram Global as its price is falling. OGI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organigram Global? A short squeeze for Organigram Global occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGI, which in turn drives the price of the stock up even further. How often is Organigram Global's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGI, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Aurora Cannabis Short Squeeze Cronos Group Short Squeeze SNDL Short Squeeze Tilray Brands Short Squeeze Village Farms International Short Squeeze Gyre Therapeutics Short Squeeze Vir Biotechnology Short Squeeze Ginkgo Bioworks Short Squeeze Xeris Biopharma Short Squeeze Replimune Group Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OGI) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
